Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04376541
Other study ID # s 43
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2016
Est. completion date April 1, 2020

Study information

Verified date May 2020
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators are measuring fentanyl consumption in micrograms used during anesthesia for patients on fast track congenital cardiac surgeries


Description:

The investigators are measuring fentanyl consumed for both fast track and conventional corrective cardiac surgeries and also parents Parental Perceptions satisfaction with early child communication in ICU and impact of caudal anesthesia on extubation time our 2ry outcomes are the hospital and ICU length of stay


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date April 1, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers No
Gender All
Age group 3 Months to 18 Years
Eligibility Inclusion Criteria:

- patients diagnosed with congenital cardiac anomaly for surgical correction.

- age limit: child 3months of age to 18 years

Exclusion Criteria:

patients with any o the following:

- emergency surgeries

- redo surgeries

- complex surgeries

- patients weight less than 3kg

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Fentanyl
amount of fentanyl used in both groups

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Outcome

Type Measure Description Time frame Safety issue
Primary fentanyl consumption amount of fentanyl used in microgram during the procedure (corrective surgery)
Primary parents satisfaction: questionnare questionnare for parents satisfaction by early child communication after discharge from the ICU up to 1 week
Secondary intensive care length of stay number of days in ICU after departure from operation room until ward discharge up to 3 weeks
Secondary hospital length of stay total number of days spent in hospital from admission until home discharge up to 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT05617976 - Nalbuphine as an Adjuvant to Levobupivacaine in Caudal Analgesia in Children N/A
Recruiting NCT06417060 - Caudal Anesthesia Versus Local Anesthesia in Hypospadias N/A
Completed NCT00938821 - Very Low Dose Caudal Morphine for Postoperative Pain Management N/A